These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34581430)
1. Modified ticagrelor loading doses according to the vasodilator-stimulated phosphoprotein phosphorylation index improve the clinical outcome in ST-elevation myocardial infarction patients with high on-treatment platelet reactivity. Liu Y; Kang S; Li X; Liu Z; Gao Y; Wang X Cardiol J; 2023; 30(5):771-780. PubMed ID: 34581430 [TBL] [Abstract][Full Text] [Related]
2. Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation. Franchi F; Rollini F; Cho JR; Bhatti M; DeGroat C; Ferrante E; Dunn EC; Nanavati A; Carraway E; Suryadevara S; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ JACC Cardiovasc Interv; 2015 Sep; 8(11):1457-1467. PubMed ID: 26404199 [TBL] [Abstract][Full Text] [Related]
3. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study. You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972 [TBL] [Abstract][Full Text] [Related]
4. Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Laine M; Panagides V; Frère C; Cuisset T; Gouarne C; Jouve B; Thuny F; Paganelli F; Alessi MC; Mancini J; Bonello L J Thromb Haemost; 2019 Dec; 17(12):2188-2195. PubMed ID: 31351022 [TBL] [Abstract][Full Text] [Related]
5. Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention. Laine M; Toesca R; Berbis J; Frere C; Barnay P; Pansieri M; Peyre JP; Michelet P; Bessereau J; Camilleri E; Helaf O; Camaleonte M; Paganelli F; Dignat-George F; Bonello L Thromb Res; 2013 Jul; 132(1):e15-8. PubMed ID: 23726090 [TBL] [Abstract][Full Text] [Related]
6. Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study. Hu C; Zhang X; Liu Y; Gao Y; Zhao X; Zhou H; Luo Y; Liu Y; Wang X BMC Cardiovasc Disord; 2018 Jun; 18(1):120. PubMed ID: 29914380 [TBL] [Abstract][Full Text] [Related]
7. On-Ticagrelor Platelet Reactivity and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. Laine M; Panagides V; Frère C; Cuisset T; Gouarne C; Jouve B; Lemesle G; Paganelli F; Alessi MC; Mancini J; Bonello L Thromb Haemost; 2021 Jul; 121(7):923-930. PubMed ID: 33260230 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. Lee YS; Jin CD; Kim MH; Guo LZ; Cho YR; Park K; Park JS; Park TH; Kim YD Circ J; 2015; 79(6):1248-54. PubMed ID: 25959558 [TBL] [Abstract][Full Text] [Related]
9. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study. Silvain J; Storey RF; Cayla G; Esteve JB; Dillinger JG; Rousseau H; Tsatsaris A; Baradat C; Salhi N; Hamm CW; Lapostolle F; Lassen JF; Collet JP; Ten Berg JM; Van't Hof AW; Montalescot G Thromb Haemost; 2016 Aug; 116(2):369-78. PubMed ID: 27196998 [TBL] [Abstract][Full Text] [Related]
10. Modifying clopidogrel maintenance doses according to vasodilator-stimulated phosphoprotein phosphorylation index improves clinical outcome in patients with clopidogrel resistance. Wang XD; Zhang DF; Zhuang SW; Lai Y Clin Cardiol; 2011 May; 34(5):332-8. PubMed ID: 21538380 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in patients with acute myocardial infarction). Zeymer U; Mochmann HC; Mark B; Arntz HR; Thiele H; Diller F; Montalescot G; Zahn R JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):147-154. PubMed ID: 25616919 [TBL] [Abstract][Full Text] [Related]
12. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341 [TBL] [Abstract][Full Text] [Related]
13. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction. Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs). Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703 [TBL] [Abstract][Full Text] [Related]
15. Design and Rationale of the APELOT Trial: A Randomized, Open-Label, Multicenter, Phase IV Study to Evaluate the Antiplatelet Effect of Different Loading Dose of Ticagrelor in Patients With Non-ST Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Liu HL; Wei YJ; Jin ZG; Zhang J; Ding P; Yang SL; Luo JP; Ma DX; Liu Y; Han W Medicine (Baltimore); 2016 May; 95(22):e3756. PubMed ID: 27258504 [TBL] [Abstract][Full Text] [Related]
16. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis. Montalescot G; van 't Hof AW; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Collet JP; Goodman SG; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Licour M; Merkely B; Salhi N; Silvain J; Storey RF; Ten Berg JM; Tsatsaris A; Zeymer U; Vicaut E; Hamm CW; JACC Cardiovasc Interv; 2016 Apr; 9(7):646-56. PubMed ID: 26952907 [TBL] [Abstract][Full Text] [Related]
17. Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial. Vivas D; Jiménez JJ; Martín-Asenjo R; Bernardo E; Ortega-Pozzi MA; Gómez-Polo JC; Moreno G; Vilacosta I; Pérez-Villacastín J; Fernández-Ortiz A J Thromb Thrombolysis; 2023 Feb; 55(2):203-210. PubMed ID: 36480147 [TBL] [Abstract][Full Text] [Related]
18. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis. Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention. Zhao Z; Wang J; Lei M; Li Y; Yang Y; An L; Sun X; Li C; Xue Z BMC Cardiovasc Disord; 2023 Mar; 23(1):168. PubMed ID: 36991321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]